| Human Cell Design–Revvity: investment, 202609–acquisition €na of Human Cell Design by Revvity |
2026-09-09 |
| Adaptyv Biosystems–ACE Ventures: investment, 202608 financing round Series A totalling $40m incl existing + co-investor ACE Ventures |
2026-08-25 |
| Adaptyv Biosystems–byFounders: investment, 202608 financing round Series A totalling $40m incl existing + co-investor byFounders |
2026-08-25 |
| Adaptyv Biosystems–Highland Europe: investment, 202608 financing round Series A totalling $40m incl lead investor Highland Europe |
2026-08-25 |
| Adaptyv Biosystems–SEVERAL: investment, 202608 financing round Series A $40m led by Highland Europe |
2026-08-25 |
| Adaptyv Biosystems–Y Combinator: investment, 202608 financing round Series A totalling $40m incl existing + co-investor Y Combinator |
2026-08-25 |
| Pixelgen Technologies–Flat Capital: investment, 202608 financing round Series B totalling $15.5m incl new + lead investor Flat Capital |
2026-08-20 |
| Pixelgen Technologies–SEVERAL: investment, 202608 financing round Series B $15.5m led by new investor Flat Capital |
2026-08-20 |
| Pixelgen Technologies–Sweden (govt): investment, 202608 financing round Series B totalling $15.5m incl existing + co-investor Industrifonden |
2026-08-20 |
| Pixelgen Technologies–Wallenberg: investment, 202608 financing round Series B totalling $15.5m incl existing + co-investor Navigare Ventures |
2026-08-20 |
| Atinary Technologies–Bruker: investment, 202608 minority investment €na by Bruker in connection with strategic collaboration |
2026-08-11 |
| Mimetas–Bruker: investment, 202606 majority investment €na by Bruker |
2026-08-10 |
| Anaquant–Clean Biologics: investment, 202607 acquisition €na of Anaquant SAS by Clean Cells backed by Archimed (maybe asset deal?) |
2026-07-30 |
| Stem Genomics–Clean Biologics: investment, 202606 acquisition €na of Stem Genomics by Clean Cells backed by Archimed |
2026-06-18 |
| RG Discovery–Pelago Bioscience: investment, 202606 acquisition of RG Discovery by Pelago Bioscience |
2026-06-15 |
| KPL ApS–Genovis: investment, 202606 acquisition 100% DKK30.5m upfront with DKK11.1m cash + DKK19.4m shares plus earn-outs for founders |
2026-06-01 |
| Alamar Biosciences–SEVERAL: investment, 202604 IPO $191.25m+$28.688m with 11.25m+1.688m shares common stock incl full over-allotment at Nasdaq |
2026-04-20 |
| Proteins.1–Cloudberry VC: investment, 202604 pre-seed financing round totalling €4.7m incl investor Cloudberry VC |
2026-04-16 |
| Proteins.1–Lifeline Ventures: investment, 202604 pre-seed financing round totalling €4.7m incl investor Lifeline Ventures |
2026-04-16 |
| Proteins.1–SEVERAL: investment, 202604 pre-seed financing round €4.7m with Lifeline Ventures + Cloudberry VC |
2026-04-16 |
| ProteomEdge–OTHER: investment, 202603 2nd financing round totalling SEK8m incl existing investors |
2026-03-25 |
| ProteomEdge–SEVERAL: investment, 202603 2nd financing round SEK8m led by Navigare Ventures + incl existing investors |
2026-03-25 |
| ProteomEdge–Wallenberg: investment, 202603 2nd financing round totalling SEK8m incl existing + lead investor Navigare Ventures |
2026-03-25 |
| Plasmion–Shimadzu: investment, 202603 acquisition 75% majority by Shimadzu with founders continuing to hold 25% |
2026-03-23 |
| Biocare Medical–Agilent: investment, 200603 acquisitiion $950m in cash by Agilent from investor group led by Excellere Parnters + GHO Capital Partners |
2026-03-09 |
| Cubase Bio–Almi Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Almi Invest |
2026-02-17 |
| Cubase Bio–EU (govt): grant, 202602c grant €2m from EIC Transition Programme |
2026-02-17 |
| Cubase Bio–Illumina: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Illumina Ventures |
2026-02-17 |
| Cubase Bio–Life Science Invest: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Life Science Invest |
2026-02-17 |
| Cubase Bio–Nordic Science Investments: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor NSI |
2026-02-17 |
| Cubase Bio–OTHER: investment, 202602 financing totalling €3.9m in private capital + convertibles incl several undisclosed private investors |
2026-02-17 |
| Cubase Bio–SEVERAL: investment, 202602 CubaseBio emerges with €3.9m in financing in private capital + convertibles(!) |
2026-02-17 |
| Cubase Bio–Voima Ventures: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-lead investor Voima Ventures |
2026-02-17 |
| Masimo–Danaher: investment, 202602– acquisition $9.9b in cash net of cash/debt at $180/share SIGNED |
2026-02-17 |
| Accellix–Mérieux: investment, 202601 acquisition remaining 90% of Accellix by bioMérieux for €35m in cash |
2026-01-22 |
| Nuclera–SEVERAL: investment, 202601 financing round Series C extension $12m bringing total Series C to $87m |
2026-01-13 |
| PathoQuest–Charles River: investment, 202601– acquisition of PathoQuest by Charles River SIGNED |
2026-01-12 |
| TOFwerk–Bruker: investment, 202601 acquisition of remaining 60% ownership stake €na by Bruker |
2026-01-08 |
| Sopat–Endress+Hauser: investment, 202601 acquisition €na of Sopat GmbH + sub Parsum GmbH by Endres+Hauser |
2026-01-01 |
| Tescan–Shimadzu: investment, 202512– acquisition $678m of Tescan a.s. from Carlyle |
2025-12-25 |
| Molzym–Bruker: investment, 202511 acquisition of Molzym by Bruker |
2025-11-26 |
| Exact Sciences–Abbott: investment, 202511– acquisition $21b via cash tender offer at $105/share ANNOUNCED |
2025-11-20 |
| Evosep–Nordic Capital: investment, 202511 investment €na making Nordic Capital majority shareholder of Evosep |
2025-11-18 |
| ACD/Labs–Revvity: investment, 202511– acquisition of ACD/Labs by Revvity definitive agreement announced |
2025-11-10 |
| Envue Technologies–NanoTemper: investment, 202511 acquisition of Envue by NanoTemper |
2025-11-05 |
| EMC Industrial Group (NZ)–Endress+Hauser: investment, 202511 acquisition of process measurement business of EMC + integration into EH New Zealand |
2025-11-01 |
| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Redberry–Lonza: investment, 202510–202601 acquisition of Redberry SAS by Lonza |
2025-10-27 |
| JSR Corp–Merck (DE): investment, 202510–202604 acquisition of JSR Life Sciences chromatography business in Belgium by Merck |
2025-10-15 |
| Labomatic Instruments–Knauer: investment, 202510 acquisition of Labomatic by Knauer |
2025-10-15 |
| BigOmics–SEVERAL: investment, 202510 financing round 1st tranche $1.6m from Diffusion Capital Partners + business angels + TiVentures et al |
2025-10-08 |
| Adaptyv Biosystems–ACE Ventures: investment, 2025 seed financing round totalling $8m incl lead investor ACE Ventures |
2025-09-18 |
| Adaptyv Biosystems–byFounders: investment, 2025 seed financing round totalling $8m incl existing + co-investor byFounders |
2025-09-18 |
| Adaptyv Biosystems–Founderful: investment, 2025 seed financing round totalling $8m incl existing + co-investor Founderful |
2025-09-18 |
| Adaptyv Biosystems–LongGame: investment, 2025 seed financing round totalling $8m incl new + co-investor LongGame |
2025-09-18 |
| Adaptyv Biosystems–OTHER: investment, 2025 seed financing round totalling $8m incl angel investors |
2025-09-18 |
| Adaptyv Biosystems–SEVERAL: investment, 2025 seed financing round $8m led by ACE Ventures |
2025-09-18 |
| Aspect Analytics–SEVERAL: investment, 202509 financing round Series A €10m led by PMV + Capricorn Healthtech Fund II |
2025-09-09 |
| Dash Bio–Aligned Fund: investment, 202507 financing round totalling $11m incl lead investor The Aligned Fund |
2025-07-23 |
| Dash Bio–Cybernetix Ventures: investment, 202507 financing round totalling $11m incl co-investor Cybernetix Ventures |
2025-07-23 |
| Dash Bio–Drive Capital: investment, 202507 financing round totalling $11m incl co-investor Drive Capital |
2025-07-23 |
| Dash Bio–Freestyle Capital: investment, 202507 financing round totalling $11m incl co-investor Freestyle Capital |
2025-07-23 |
| Dash Bio–LifeX Ventures: investment, 202507 financing round totalling $11m incl co-investor LifeX Ventures |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Dash Bio–Swift Ventures: investment, 202507 financing round totalling $11m incl co-investor Swift Ventures |
2025-07-23 |
| Becton Dickinson–Waters: investment, 202507–202602 merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Applied Technical Services–SGS: investment, 202507–202601 acquisition $1.235b cash-/debt-free with <$100m in shares + rest in cash |
2025-07-02 |
| CodeWrights–Endress+Hauser: investment, 202507 acquisition of remaining 33% in joint venture CodeWrights GmbH from Pepperl+Fuchs |
2025-07-01 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Cytespace Africa Laboratories–MLM Medical Labs: investment, 202506 acquisition of Cytespace by MLM |
2025-06-03 |
| ProteomEdge–OTHER: investment, 202505 financing round totalling SEK7.8m incl existing investors |
2025-05-29 |
| ProteomEdge–SEVERAL: investment, 202505 financing round SEK7.8m led by Navigare Ventures + incl existing investors |
2025-05-29 |
| ProteomEdge–Wallenberg: investment, 202505 financing round totalling SEK7.8m incl lead investor Navigare Ventures |
2025-05-29 |
| Halo Labs–Waters: investment, 202505 acquisiton of Halo Labs by Waters |
2025-05-21 |
| Umlaut.bio–Baden-Würrtemberg (govt): investment, <=202505 seed financing round incl investor L-Bank via InnoGrowth BW programme |
2025-05-13 |
| Umlaut.bio–High-Tech Gründerfonds: investment, <=202505 seed financing round incl investor HTGF |
2025-05-13 |
| Umlaut.bio–LBBW: investment, <=202505 seed financing round incl investor LBBW Venture Capital |
2025-05-13 |
| Umlaut.bio–SEVERAL: investment, <=202505 seed financing round €2m with HTGF + LBBW Venture Capital + L-Bank |
2025-05-13 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Recipe–Bruker: investment, 202504 majority investment €na by Bruker in Recipe Chemicals + Instruments GmbH |
2025-04-16 |
| Ridom–Bruker: investment, 202504 majority investment €na by Bruker in Ridom GmbH |
2025-04-11 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| UniteLabs–Acurio Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor Acurio Ventures |
2025-04-03 |
| UniteLabs–Lana Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor LANA Ventures |
2025-04-03 |
| UniteLabs–NAP: investment, 202504 pre-seed financing round totalling €2.77m incl lead investor NAP |
2025-04-03 |
| UniteLabs–OMA Business Angels: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor OMA Business Angels |
2025-04-03 |
| UniteLabs–Push Ventures: investment, 202504 pre-seed financing round totalling €2.77m incl co-investor PUSH |
2025-04-03 |
| UniteLabs–SEVERAL: investment, 202504 pre-seed financing round €2.77m led by NAP |
2025-04-03 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| DeepEn–MBG Thüringen: investment, 202502 seed financing round totalling € 7-digit incl investor MBG Thüringen |
2025-02-17 |
| DeepEn–SEVERAL: investment, 202502 seed financing round € 7-digit from bm|t + MBG Thüringen + Sparkasse-Jena-Holzland |
2025-02-17 |
| DeepEn–Sparkassen (DE): investment, 202502 seed financing round totalling € 7-digit incl investor Sparkasse Jena-Saale-Holzland |
2025-02-17 |
| DeepEn–Thuringia (govt): investment, 202502 seed financing round totalling € 7-digit incl investor bm|t |
2025-02-17 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
